文献速递中医骨伤中药与中成药合理使用

续断生品与酒制品干预去卵巢大鼠雌激素缺乏的代谢组学证据

Global and untargeted metabolomics evidence of the protective effect of different extracts of Dipsacus asper Wall. ex C.B. Clarke on estrogen deficiency after ovariectomia in rats.
PubMed 文献 · J Ethnopharmacol · 2017-01-26

研究用去卵巢大鼠模型,通过GC-MS代谢组学分析续断生品与酒制品对血清、肝、肾代谢轮廓的影响。结果表明续断及酒续断均可回调差异代谢物,涉及氨基酸、碳水化合物和能量代谢通路,从而发挥抗骨质疏松作用。

要点

  • 续断生品与酒制品均能回调去卵巢大鼠的代谢紊乱。
  • 主要干预通路包括苯丙氨酸、酪氨酸、色氨酸生物合成及支链氨基酸生物合成等。
  • 代谢组学可辅助验证中药抗骨质疏松的药效及机制。

核心结论

  • 续断生品和酒制品均可通过干预氨基酸代谢、碳水化合物代谢和能量代谢预防去卵巢大鼠骨质疏松。

研究设计与样本

  • 25只雌性Wistar大鼠分为假手术组、模型组、E2组、生续断组和酒续断组,灌胃给药16周后采集血清、肝、肾进行GC-MS代谢组学分析。

主要发现

  • PCA得分图显示假手术组、模型组和治疗组间有清晰分离趋势。
  • 生续断组和酒续断组分别鉴定出80和74个代谢生物标志物。
  • 主要干预通路为苯丙氨酸、酪氨酸和色氨酸生物合成,缬氨酸、亮氨酸和异亮氨酸生物合成,甲烷代谢,甘氨酸、丝氨酸和苏氨酸代谢,以及半乳糖代谢。
  • 与模型组相比,给予生续断和酒续断后所有生物标志物水平逐渐恢复正常。

临床怎么用

  • 续断生品与酒制品均可用于雌激素缺乏相关骨质疏松的干预,其机制涉及多代谢通路调节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Dipsacus asper Wall. ex C.B. Clarke (DA) is an effectively traditional Chinese medicine for treating osteoporosis and bone fracture. Until now, studies on pharmacological mechanism of DA mostly centered on cell and gene level, little is known about its metabolic signatures. The aim of this study is to investigate the anti-osteoporosis effects of crude and wine-processed DA by global and untargeted metabolic profiling of rats serum, liver and kidney derived from sham, model and treated groups. METHOD: A total of 25 female Wistar rats were divided into five groups: sham group, model group, E2, crude and wine-processed DA treated group. The treatment rats were orally administered 17β-estradiol, crude and wine-processed DA extract at a therapeutic dose once daily throughout the experimental period, while sham group and model group were orally gavaged approximately volume of saline solution. After 16 weeks, all serum, liver and kidney samples of five groups were collected and their metabolomic alterations were monitored by gas chromatography-mass spectrometry (GC-MS). The resulting dataset was analyzed by principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA). The identification of all potential biomarkers was performed using reference standard or NIST library. Moreover, clinical chemistry and biomechanical analysis were also performed to ensure the success of the osteoporosis model and to validate the anti-osteoporosis effect of crude and wine-processed DA. RESULTS: Clear separation trend among sham, model and treatment group was observed in PCA score plot. The anti-osteoporosis effect of DA and wine-processed DA can be indicated in PLS-DA score plots. A total of 80 and 74 metabolite biomarkers were identified for DA and wine-processed DA treated groups, respectively. Pathway analysis revealed that phenylalanine, tyrosine and tryptophan biosynthesis, valine, leucine and isoleucine biosynthesis, methane metabolism, glycine, serine and threonine metabolism, galactose metabolism were the major intervened pathways. Compared with model group, levels of all biomarkers were gradually restored to normal after administration of DA and wine-processed DA. CONCLUSION: The anti-osteoporosis effect of DA and wine-processed DA has been reliably confirmed by the metabolomics approach. The osteoporosis might be prevented by DA and wine-processed DA via intervening amino acid metabolism, carbohydrate metabolism and energy metabolism in vivo in rats.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Tao Y, Chen X, Li W, et al. Global and untargeted metabolomics evidence of the protective effect of different extracts of Dipsacus asper Wall. ex C.B. Clarke on estrogen deficiency after ovariectomia in rats. J Ethnopharmacol. 2017. PMID: 28132861. doi:10.1016/j.jep.2017.01.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。